Editas Medicine, Inc.
US ˙ NasdaqGS ˙ US28106W1036

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Akshay Vaishnaw. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Akshay Vaishnaw har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:SRRK / Scholar Rock Holding Corporation President of R&D, Director 616 205
US:ALNY / Alnylam Pharmaceuticals, Inc. President 22 774
US:EDIT / Editas Medicine, Inc. Director 11 538
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Akshay Vaishnaw. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp EDIT / Editas Medicine, Inc. - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i EDIT / Editas Medicine, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

EDIT / Editas Medicine, Inc. Insider Trades
Internhandel EDIT / Editas Medicine, Inc. - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i EDIT / Editas Medicine, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

EDIT / Editas Medicine, Inc. Insider Trades
Internkjøp SRRK / Scholar Rock Holding Corporation - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i EDIT / Editas Medicine, Inc.. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

SRRK / Scholar Rock Holding Corporation Insider Trades
Internhandel SRRK / Scholar Rock Holding Corporation - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i EDIT / Editas Medicine, Inc.. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

SRRK / Scholar Rock Holding Corporation Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Akshay Vaishnaw som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-05-30 2025-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X −1 620 616 205 −0,26 30,01 −48 612 18 490 587
2025-05-30 2025-05-29 4 SRRK Scholar Rock Holding Corp
Common Stock
S - Sale X −5 130 617 825 −0,82 29,63 −152 000 18 305 969
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 500 000 622 955 406,65
2025-04-29 2025-04-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 100 000 122 955 435,63
2024-07-01 2024-06-27 4 SRRK Scholar Rock Holding Corp
Common Stock
A - Award 13 500 22 955 142,78
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −192 22 774 −0,84 189,31 −36 348 4 311 346
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −17 22 966 −0,07 188,40 −3 203 4 326 794
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −101 22 983 −0,44 187,37 −18 924 4 306 325
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −1 107 23 084 −4,58 186,39 −206 334 4 302 627
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −1 869 24 191 −7,17 185,54 −346 774 4 488 398
2023-08-07 2023-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −771 26 060 −2,87 184,70 −142 404 4 813 282
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3 859 26 831 16,80
2023-08-07 2023-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 082 22 972 28,41
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −168 17 890 −0,93 197,08 −33 109 3 525 761
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −104 18 058 −0,57 195,65 −20 348 3 533 048
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −1 013 18 162 −5,28 194,94 −197 474 3 540 500
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −910 19 175 −4,53 193,93 −176 476 3 718 608
2023-04-28 2023-04-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale −197 20 085 −0,97 193,18 −38 056 3 880 020
2023-04-28 2023-04-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 312 20 282 35,48
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 302 14 970 −22,32 217,05 −933 749 3 249 238
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −19 447 19 272 −50,23 216,38 −4 207 942 4 170 075
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 279 38 719 −20,98 215,59 −2 216 050 8 347 429
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 307 48 998 −4,50 214,28 −494 344 10 499 291
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 709 51 305 −3,22 213,13 −364 239 10 934 635
2023-02-14 2023-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 30 913 53 014 139,87 63,00 1 947 519 3 339 882
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −1 324 22 101 −5,65 226,20 −299 489 4 999 246
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 2 368 23 425 11,25 42,22 99 977 989 004
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1 587 21 057 8,15 63,00 99 981 1 326 591
2022-12-07 2022-12-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1 124 19 470 6,13 88,95 99 980 1 731 856
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −198 18 346 −1,07 210,75 −41 728 3 866 420
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −180 18 544 −0,96 210,66 −37 919 3 906 479
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −195 18 724 −1,03 210,22 −40 993 3 936 159
2022-08-05 2022-08-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −5 479 18 919 −22,46 189,76 −1 039 695 3 590 069
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 3 859 24 398 18,79
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 4 241 20 539 26,02
2022-08-05 2022-08-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 083 16 298 45,32
2022-05-27 2022-05-26 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 28 000 28 000
2022-02-25 2022-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 29 842 29 842
2022-01-04 2021-12-31 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 22 380 22 380
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −303 11 215 −2,63 195,11 −59 118 2 188 159
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −145 11 518 −1,24 193,67 −28 082 2 230 691
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −126 11 663 −1,07 193,37 −24 365 2 255 274
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −73 11 789 −0,62 192,25 −14 034 2 266 435
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 000 11 862 −7,77 191,45 −191 450 2 270 980
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −125 12 862 −0,96 190,86 −23 858 2 454 841
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −142 12 987 −1,08 190,39 −27 035 2 472 595
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −73 13 129 −0,55 190,33 −13 894 2 498 843
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −5 13 202 −0,04 190,27 −951 2 511 945
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −144 13 207 −1,08 190,02 −27 363 2 509 594
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −144 13 351 −1,07 189,24 −27 251 2 526 543
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 13 495 −0,06 189,18 −1 513 2 552 984
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −73 13 503 −0,54 189,01 −13 798 2 552 202
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −127 13 576 −0,93 188,26 −23 909 2 555 818
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −130 13 703 −0,94 187,35 −24 356 2 567 257
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −137 13 833 −0,98 187,08 −25 630 2 587 878
2021-12-23 2021-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −124 13 970 −0,88 186,22 −23 091 2 601 493
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −122 14 094 −0,86 186,48 −22 751 2 628 249
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −1 14 216 −0,01 190,50 −190 2 708 148
2021-12-23 2021-12-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −2 415 14 217 −14,52 189,13 −456 749 2 688 861
2021-12-23 2021-12-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 417 16 632 48,30
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
M - Exercise X −10 834 10 832 −50,00
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 834 11 215 −49,14 200,00 −2 166 800 2 243 000
2021-08-11 2021-08-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10 834 22 049 96,60 63,00 682 542 1 389 087
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −970 2 368 −29,06
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
M - Exercise X −10 834 21 666 −33,34
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −14 708 11 215 −56,74 175,00 −2 573 900 1 962 625
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 970 25 923 3,89 42,22 40 953 1 094 469
2021-06-22 2021-06-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 10 834 24 953 76,73 63,00 682 542 1 572 039
2021-06-07 2021-06-03 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11 538 11 538
2021-06-01 2021-05-27 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 7 800 7 800
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −107 14 119 −0,75 138,48 −14 817 1 955 199
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −530 14 226 −3,59 137,60 −72 928 1 957 498
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 892 14 756 −11,36 136,84 −258 901 2 019 211
2021-04-21 2021-04-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −203 16 648 −1,20 135,41 −27 488 2 254 306
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −85 16 851 −0,50 134,56 −11 438 2 267 528
2021-04-21 2021-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −2 266 16 936 −11,80 131,75 −298 546 2 231 318
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −417 19 202 −2,13 140,02 −58 388 2 688 664
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −622 19 619 −3,07 138,64 −86 234 2 719 978
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −989 20 241 −4,66 137,60 −136 086 2 785 162
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 678 21 230 −7,32 136,76 −229 483 2 903 415
2021-04-21 2021-04-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 083 22 908 28,52
2021-02-26 2021-02-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 28 800 28 800
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −92 17 825 −0,51 152,53 −14 033 2 718 847
2021-02-16 2021-02-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −1 618 17 917 −8,28 156,00 −252 408 2 795 052
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8 334 25 000 50,01
2021-02-16 2021-02-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 416 19 535 38,36
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −971 3 338 −22,53
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −971 14 119 −6,43 140,00 −135 940 1 976 660
2020-10-01 2020-09-29 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 971 15 090 6,88 42,22 40 996 637 100
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −970 4 309 −18,37
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −195 14 119 −1,36 152,97 −29 829 2 159 783
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −334 14 314 −2,28 152,22 −50 841 2 178 877
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −180 14 648 −1,21 150,34 −27 061 2 202 180
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −83 14 828 −0,56 149,09 −12 374 2 210 707
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −178 14 911 −1,18 148,48 −26 429 2 213 985
2020-06-24 2020-06-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 970 15 089 6,87 42,22 40 953 637 058
2020-06-18 2020-06-16 4 SRRK Scholar Rock Holding Corp
Stock Option (right to buy)
A - Award 13 000 13 000
2020-06-12 2020-06-10 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11 538 11 538
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −971 5 279 −15,54
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X −21 000 0 −100,00
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −21 971 14 119 −60,88 140,00 −3 075 940 1 976 660
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 971 36 090 2,76 42,22 40 996 1 523 720
2020-04-22 2020-04-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 21 000 35 119 148,74 42,22 886 620 1 482 724
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −98 14 119 −0,69 106,52 −10 439 1 503 956
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −2 415 14 217 −14,52 104,75 −252 971 1 489 231
2020-04-09 2020-04-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 5 417 16 632 48,30
2020-02-28 2020-02-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 27 623 27 623
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −18 750 6 250 −75,00
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
M - Exercise X −4 000 21 000 −16,00
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −23 708 11 215 −67,89 125,00 −2 963 500 1 401 875
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4 000 34 923 12,94 42,22 168 880 1 474 449
2020-02-11 2020-02-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18 750 30 923 154,03 42,22 791 625 1 305 569
2019-12-26 2019-12-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8 333 16 666 100,00
2019-11-26 2019-11-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2017 (right to buy)
A - Award 8 333 8 333
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6 250 25 000 33,33
2019-08-07 2019-08-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7 500 30 000 33,33
2019-08-07 2019-07-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 48 515 10,28
2019-06-14 2019-06-12 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11 538 11 538
2019-06-07 2019-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6 250 18 750 50,00
2019-06-07 2019-04-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 51 467 12,26
2019-06-07 2018-10-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 21 416 5,32
2019-05-23 2019-05-21 4 SRRK Scholar Rock Holding Corp
Stock Option (Right to Buy)
A - Award 20 316 20 316
2019-03-01 2019-02-28 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32 500 32 500
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2016 (right to buy)
A - Award 6 250 12 500 100,00
2018-09-28 2018-09-27 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7 500 22 500 50,00
2018-08-23 2018-08-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7 500 15 000 100,00
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −766 12 173 −5,92 90,95 −69 668 1 107 134
2018-08-14 2018-08-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 1 724 12 939 15,37
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2014 (right to buy)
A - Award 11 707 35 125 49,99
2018-08-14 2018-08-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2013 (right to buy)
A - Award 10 832 32 500 49,99
2018-08-14 2018-07-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 29 395 7,92
2018-08-14 2018-04-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
J - Other 28 366 8,28
2018-06-19 2018-06-15 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11 538 11 538
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −44 641 0 −100,00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −38 913 0 −100,00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −5 000 0 −100,00
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 380 11 215 −36,26 145,27 −926 823 1 629 203
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −20 172 17 595 −53,41 144,53 −2 915 459 2 543 005
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −19 213 37 767 −33,72 143,46 −2 756 297 5 418 054
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −21 336 56 980 −27,24 142,57 −3 041 874 8 123 639
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −15 000 78 316 −16,07 141,69 −2 125 350 11 096 594
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 453 93 316 −6,47 140,45 −906 324 13 106 232
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5 000 99 769 5,28 7,10 35 500 708 360
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 38 913 94 769 69,67 16,43 639 341 1 557 055
2018-03-16 2018-03-14 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 44 641 55 856 398,05 18,66 833 001 1 042 273
2018-03-05 2018-03-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25 000 25 000
2017-12-21 2017-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Based Stock Option 2016 (right to buy)
A - Award 6 250 6 250
2017-12-21 2017-12-19 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
G - Gift −320 11 215 −2,77
2017-11-08 2017-11-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2015 (right to buy)
A - Award 7 500 7 500
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −33 666 0 −100,00
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 693 11 535 −24,25 122,79 −453 463 1 416 383
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −17 755 15 228 −53,83 121,69 −2 160 606 1 853 095
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −11 418 32 983 −25,72 120,78 −1 379 066 3 983 687
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −800 44 401 −1,77 119,79 −95 832 5 318 796
2017-11-01 2017-10-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 33 666 45 201 291,86 21,35 718 769 965 041
2017-09-22 2017-09-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2013 (right to buy)
A - Award 10 834 10 834
2017-07-11 2017-07-07 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 11 709 23 418 100,00
2017-06-19 2017-06-15 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 11 538 11 538
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −328 33 666 −0,96
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −1 340 44 641 −2,91
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −430 11 535 −3,59 74,31 −31 953 857 166
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1 340 11 965 12,61 18,66 25 004 223 267
2017-06-15 2017-06-13 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 328 10 625 3,19 21,35 7 003 226 844
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −11 000 33 994 −24,45
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −11 000 10 297 −51,65 75,00 −825 000 772 275
2017-05-25 2017-05-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11 000 21 297 106,83 21,35 234 850 454 691
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −32 750 0 −100,00
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −11 000 44 994 −19,64
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −11 000 10 297 −51,65 65,00 −715 000 669 305
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11 000 21 297 106,83 21,35 234 850 454 691
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −32 750 10 297 −76,08 65,00 −2 128 750 669 305
2017-05-17 2017-05-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 32 750 43 047 318,05 31,39 1 028 022 1 351 245
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −4 356 55 994 −7,22
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −4 019 45 981 −8,04
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −1 172 38 913 −2,92
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −5 000 10 297 −32,69 37,44 −187 200 385 520
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4 356 15 297 39,81 21,35 93 001 326 591
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4 019 10 941 58,06 18,66 74 995 204 159
2017-01-04 2016-12-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 1 172 6 922 20,38 16,43 19 256 113 728
2016-12-22 2016-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 25 000 25 000
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −29 165 0 −100,00
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 500 5 750 −20,69 46,14 −69 208 265 298
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −13 297 7 250 −64,72 45,55 −605 662 330 229
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −14 368 20 547 −41,15 44,34 −637 127 911 126
2016-12-02 2016-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 29 165 34 915 507,22 22,75 663 504 794 316
2016-07-29 2016-07-28 4 EDIT Editas Medicine, Inc.
Stock Option (right to buy)
A - Award 23 076 23 076
2016-07-29 3 EDIT Editas Medicine, Inc.
No securities are beneficially owned
0
2016-02-25 2016-02-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 10 000 10 000
2016-02-03 2016-02-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance Stock Option 2014 (right to buy)
A - Award 11 709 11 709
2015-12-22 2015-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 30 000 30 000
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −835 29 165 −2,78
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise −4 915 40 085 −10,92
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 4 915 5 750 588,62 16,43 80 753 94 472
2015-11-30 2015-11-25 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise 835 835 22,75 18 996 18 996
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −6 250 0 −100,00
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −2 500 5 000 −33,33
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −350 0 −100,00 131,00 −45 850
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 800 350 −83,72 130,06 −234 100 45 519
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 667 2 150 −55,37 128,79 −343 479 276 895
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 933 4 817 −44,95 128,10 −503 811 617 050
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 8 750 40,00 7,10 17 750 62 125
2015-06-18 2015-06-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 6 250 9,30 58 125 58 125
2015-05-05 2015-05-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 35 125 35 125
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 250 6 250 −50,00
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −2 500 7 500 −25,00
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −644 0 −100,00 119,38 −76 881
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 000 644 −60,83 118,16 −118 160 76 095
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 080 1 644 −55,85 117,35 −244 088 192 923
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 802 3 724 −50,52 116,34 −442 325 433 250
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 224 7 526 −13,99 115,29 −141 115 867 673
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 8 750 40,00 7,10 17 750 62 125
2015-03-19 2015-03-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 6 250 9,30 58 125 58 125
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 251 12 500 −33,34
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −1 875 0 −100,00
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −2 500 10 000 −20,00
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −100 0 −100,00 95,00 −9 500
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −5 090 100 −98,07 94,40 −480 514 9 440
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 936 5 190 −36,13 93,42 −274 273 484 836
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 900 8 126 −18,95 92,33 −175 420 750 244
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −600 10 026 −5,65 91,47 −54 880 917 045
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 10 626 30,77 7,10 17 750 75 445
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 251 8 126 333,39 9,30 58 134 75 572
2014-12-16 2014-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1 875 1 875 9,14 17 138 17 138
2014-12-16 2014-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Performance-Based Stock Option (Right to Buy)
A - Award 10 834 10 834
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 250 18 751 −25,00
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −1 875 1 875 −50,00
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −2 500 12 500 −16,67
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −800 0 −100,00 73,03 −58 422
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 625 800 −89,23 72,27 −478 766 57 813
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 200 7 425 −30,12 71,34 −228 275 529 669
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 10 625 30,77 7,10 17 750 75 438
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 8 125 333,33 9,30 58 125 75 562
2014-09-17 2014-09-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1 875 1 875 9,14 17 138 17 138
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −6 250 25 001 −20,00
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −1 875 3 750 −33,33
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −2 500 15 000 −14,29
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 127 0 −100,00 69,97 −568 620
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 498 8 127 −23,51 69,33 −173 178 563 418
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 10 625 142,86 9,30 58 125 98 812
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 4 375 133,33 7,10 17 750 31 062
2014-06-19 2014-06-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1 875 1 875 9,14 17 138 17 138
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −22 145 0 −100,00
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −6 249 31 251 −16,66
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −1 875 5 625 −25,00
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −2 500 17 500 −12,50
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 944 0 −100,00 75,15 −146 094
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −22 044 1 944 −91,90 74,08 −1 633 110 144 019
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 781 23 988 −26,80 73,34 −644 020 1 759 337
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 500 32 769 8,26 7,10 17 750 232 660
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 249 30 269 26,02 9,30 58 116 281 502
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1 875 24 020 8,47 9,14 17 138 219 543
2014-03-20 2014-03-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 22 145 22 145 12,96 286 999 286 999
2014-02-25 2014-02-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
I - Other −2 615 0 −100,00 90,10 −235 612
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −700 0 −100,00 87,44 −61 208
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 100 700 −61,11 86,60 −95 260 60 620
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 221 1 800 −70,10 85,77 −362 056 154 395
2014-01-27 2014-01-24 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 869 6 021 −23,69 84,57 −158 065 509 207
2014-01-27 2014-01-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
F - Taxes −4 698 7 890 −37,32 89,49 −420 424 706 076
2013-12-18 2013-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 32 500 32 500
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −18 480 22 145 −45,49
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −9 980 12 588 −44,22 61,40 −612 762 772 891
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −8 500 22 568 −27,36 60,59 −514 999 1 367 352
2013-12-18 2013-12-17 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 18 480 31 068 146,81 12,96 239 501 402 641
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −6 250 37 500 −14,29
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −3 750 7 500 −33,33
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −5 000 20 000 −20,00
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 256 12 588 −25,27 60,78 −258 669 765 068
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 744 16 844 −38,94 60,19 −646 629 1 013 758
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5 000 27 588 22,14 7,10 35 500 195 875
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 22 588 38,25 9,30 58 125 210 068
2013-12-18 2013-12-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3 750 16 338 29,79 9,14 34 275 149 329
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 250 43 750 −12,50
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −700 12 588 −5,27 58,18 −40 724 732 333
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −5 550 13 288 −29,46 57,39 −318 514 762 598
2013-09-12 2013-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 18 838 49,65 9,30 58 125 175 193
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 250 50 000 −11,11
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −3 750 11 250 −25,00
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −5 000 25 000 −16,67
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −100 12 588 −0,79 31,75 −3 175 399 669
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 900 12 688 −27,86 31,07 −152 249 394 233
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 5 000 17 588 39,72 7,10 35 500 124 875
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 250 12 588 −33,18 31,07 −194 196 391 126
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 18 838 49,65 9,30 58 125 175 193
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −3 750 12 588 −22,95 31,07 −116 517 391 126
2013-06-13 2013-06-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3 750 16 338 29,79 9,14 34 275 149 329
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X −6 250 56 250 −10,00
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −6 250 12 588 −33,18 24,55 −153 415 308 990
2013-03-11 2013-03-11 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 18 838 49,65 9,30 58 125 175 193
2012-12-21 2012-12-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 50 000 50 000
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −3 750 15 000 −20,00
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −6 250 62 500 −9,09
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −10 000 12 588 −44,27 19,00 −190 000 239 172
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 3 750 22 588 19,91 9,14 34 275 206 454
2012-12-12 2012-12-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 6 250 18 838 49,65 9,30 58 125 175 193
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −4 777 30 000 −13,74
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 777 12 588 −27,51 17,00 −81 209 213 996
2012-12-12 2012-12-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4 777 17 365 37,95 7,10 33 917 123 292
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −2 400 34 777 −6,46
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 400 12 588 −16,01 17,04 −40 896 214 500
2012-12-06 2012-12-04 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 400 14 988 19,07 7,10 17 040 106 415
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −2 823 37 177 −7,06
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −2 823 12 588 −18,32 17,03 −48 072 214 359
2012-12-04 2012-11-30 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 2 823 15 411 22,43 7,10 20 043 109 418
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −4 916 68 750 −6,67
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −4 916 12 588 −28,09 19,00 −93 404 239 172
2012-09-12 2012-09-12 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 4 916 17 504 39,05 9,30 45 719 162 787
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −1 334 73 666 −1,78
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −1 334 12 588 −9,58 19,00 −25 346 239 172
2012-09-12 2012-09-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 1 334 13 922 10,60 9,30 12 406 129 475
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −25 000 75 000 −25,00
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
M - Exercise X −11 250 18 750 −37,50
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −11 250 12 588 −47,19 19,00 −213 750 239 172
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 11 250 23 838 89,37 9,14 102 825 217 879
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X −25 000 12 588 −66,51 19,00 −475 000 239 172
2012-07-18 2012-07-16 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 25 000 37 588 198,60 9,30 232 500 349 568
2012-01-25 2012-01-23 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
A - Award 12 588 12 588
2009-03-13 3 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
799
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)